Competence of the extensor mechanism is the major determinant of functional outcome after resection of the proximal tibia and tumor prosthesis implantation. Restoration of a compromised active extension of the knee and an extension lag still remains a difficult challenge. Various techniques have been proposed in the past twenty years including direct attachment of the patellar ligament to the prosthesis, transposition of the medial gastrocnemius muscle possibly associated with other muscle flaps, transposition of the fibula and combination of these techniques. Transposition of the fibula was first reported by Kotz in 1983 but not sufficiently described, so that surgeons who want to plane and manage such a procedure can have some difficulties. We present our technique of fibula transposition and report the functional results about seven patients treated for high-grade sarcomas of the proximal tibia. Fibula transposition is carried out only if the entire fibula and its soft-tissues can be preserved. Resection of the tumor and reconstruction is carried out using the same anteromedial approach. After implantation of the prosthesis, the fibula and its muscles are mobilized anteriorly in a ‘baionnette’ shape obtained by performing a two-level osteotomy. The peroneal nerve and the anterior tibial vessels are previously identified and released to prevent tension on these structures during transposition. Care must be taken to preserve as much as possible the muscular insertions on the fibula so that probability of bone fusion increases. The biceps tendon and the lateral collateral ligament inserted in the fibular head are sutured to the patellar ligament. The knee is immobilized in a knee-ankle orthosis for 6 weeks. We have performed this technique in seven cases. A medial gastrocnemius muscle flap was associated in 3 cases to cover the prosthesis. Fusion was achieved in all cases. Full active extension was obtained in all cases with an extensor strength rated 5/5. All patients were ambulatory without external support at the last follow up.

Aims: The authors reported an original technique for proximal humerus reconstruction followed tumor resection using a delta composite prosthesis. Seven patients undergoing this technique Technique: Proximal humeral resection was conducted usually. The host tendons of rotator cuff were resected; the deltoid muscle must be preserved. The glenosphere was inserted with three screws. A long humeral stem was used to provide a distal anchorage of 10 cm; this stem was cemented into the allograft and into the humerus host. The patient was immobilized in 90¡ of abduction during 6 weeks. Results: 7 patients aged 38 to 56 years, who presented a chondro-sarcoma or an osteosarcoma of the proximal humerus were enrolled in this study. The mean follow-up was 20 months (6 to 24). None patient presented with pain and the mean of active abduction was 120¡. No local or general recurrence was detected. Discussion: The Delta prosthesis of Gramon is usually used for shoulder arthritis with rotator cuff rupture. In our experience, reconstruction of the proximal humerus with composite prosthesis provides good functional results but after 3 years, a graft resorption was observed and the functional results decrease. The delta prosthesis could provide good functional results without reconstruction of the rotator cuff. In our technique, we sutured the rotator cuff to avoid dislocation. However, the glenoid þxation is incertain for a long term because its a constrained prosthesis. This technique could be used when the deltoid muscle can be preserved.

Purpose: We report our results of revision procedures for severe acetabular loosening with saddle prostheses. The series concerned six patients, mean age 67 years age range 58–82 years, who initially presented rheumatoid disease (n=3), degenerative hip disease (n=3, one secondary to trauma), and radiation-induced hip disease (n=1). These patients had undergone one to three procedures for reconstruction with a bone graft and metal implants.

Material and methods: Failure was the indication for salvage with a saddle prosthesis due to massive loss of acetabular bone stock, complicated in five cases by an unstable hemipelvis due to transverse nonunion. An allograft was screw fixed in the iliac wing in two cases to stabilise the saddle prosthesis. Weight bearing was allowed early after surgery in all cases except two. The hip was immobilised in four cases for three to six weeks in a bermuda cast or with traction (n=4). Follow-up was 2 to 5 years.

Results: There was only one complication: stress fracture of the iliac bone at two years which did not heal. Bone graft with ostheosynthesis was proposed. Pain relief was nearly total in all cases. Four patients could walk without crutches and two walked with two crutches or an ambulator due to associated disease or alar fracture. The fixation was at 60 – 95° with abduction at 10–30°. All patients were satisfied and two felt the result was very superior to simple ablation of the prosthesis which they had experienced. Radiograpically, there was no evidence of ascension of the saddle but the risk remains at this short follow-up due to the rates described in the literature. One major migration was observed as was one stress fracture of a weak iliac bone which required removal of the implant.

Discussion: This difficult technique provides a better result and thus would be indicated for young patients able to sustain the intervention. It would be logical to associate a supporting bone graft on the iliac bone to prevent stress fracture and migration of the saddle. The saddle prosthesis appears to be the last resort after failure or insufficient results after prior reconstruction. The leading cause of failure is nonunion with hemipelvis mobility. This suggests the intervention should be considered before reaching this stage of well tolerated ace-tabular loosening.

Purpose: Primary bone tumours located in the upper limb are mainly found in the proximal portion of the humerus. Tumour resection raises difficult situations due to the sacrifice of the cuff tendons. We propose a decision making scheme for determining the best reconstruction strategy.

Material and methods: This retrospective analysis was based on 35 cases (19 massive prostheses, ten composite prostheses, three inverted prostheses and three composite arthrodeses). All the clinical and radiographic data were reviewed to examine function, active motion, pain, and use of the upper limb in everyday activities.

Results: Massive humeral prostheses provided a technically simple solution but produced mediocre functional results: painless shoulder without active motion, but preservation of elbow and forearm function. Composite humeral prostheses (prosthesis + allograft) did not, in our experience provide any gain in function compared with massive prostheses. Allografts were resorbed after four to five years. Composite arthrodesis with allograft and vascularised fibular graft provided a mobile shoulder with a useful amplitude and a pain free joint. Results persisted. The inverted Delta prostheses (Grammont) covered with allografts and with preservation of the rotator cuff tendons offered an interesting alternative with functional results superior to arthrodesis and similar to those with shoulder prostheses implanted for degenerative disease. The persistence of the glenoid anchorage remains uncertain.

Conclusions: We use the following scheme for reconstruction of the proximal humerus. Resection of the proximal humerus with preservation of the deltoid in patients in good general health: inverted composite prosthesis. Resection of the proximal humerus without preservation of the deltoid in patients in poor general health: composite arthrodesis. Resection of the proximal humerus in patients in very poor general health when complex surgery with long post-operative care is not possible: massive prosthesis.

Purpose of the study: Chordoma is a malignant neoplasm believed to arise from notochord remnants. It accounts for approximately 3 to 4 p. 100 of primary bone tumors and is localized along the axial skeleton, 50 p. 100 being sacrococcygeal. Clinical, radiographical and histological findings have been well established since the first description by Ribbert in 1894. Sacral chordomas are however difficult to manage and remain a challenge for surgeons and radiotherapists alike. The purpose of this study was to evaluate the long-term results of surgical treatment and patterns of failure in patients treated for chordoma of the sacrum in our department.

Materials and methods: This retrospective study included 11 cases of sacral chordomas treated from 1973 to 1998. Patient age ranged from 36 to 77 years (mean 59 years). Six patients were female and five male. The initial treatment was surgery in all cases including intralesional removal in two cases, marginal resection in seven and complete en bloc resection in two.

Results: Median follow-up was 6 years (1 month to 14 years). Tumoral recurrences were observed in nine cases 5 months to 8 years after treatment. In two cases, recurrence was observed 8 years after radical sacrectomy. Treatment of recurrences was partial surgical removal with radiotherapy (40 to 70 Grays). Three patients developed metastases in lungs, liver and bone, respectively. Seven patients died, two from metastatic disease. The 5-year overall survival was 64 p. 100 but only 18 p. 100 of the patients survived 10 years. Average disease-free survival was 18 p. 100 at 5 years and 0 p. 100 at 10 years.

Discussion: Chordoma is a slow-growing tumor allowing survival for several years despite recurrent disease. However, only 10 to 20 p. 100 of the patients survive free of disease at 5 years. Recurrences are frequent (45 to 80 p. 100) and often multiple. Chordoma inevitably recurs and eventually leads to death after intralesional removal or marginal resection. Radical surgery should be attempted whenever technically feasible. When performed early, particularly for smaller lesions, it offers the best chance for cure. However, tumoral recurrence can occur postoperatively despite a macroscopically complete resection. Because radiation therapy seems to be more successful in controlling microscopic disease, it should be considered as a pre- or postoperative adjuvant to a macroscopically complete resection.